Neurodegenerative Disorders Division Overview

couple

Neurodegenerative diseases arise as particular brain regions gradually fail. They are clinically characterized by the nature of the symptoms that first present, and usually manifest as changes in cognition, movement, strength, or balance.


The Neurodegenerative Disorders Division focuses on a variety of diseases, which can be divided into four groups:


Neurodegenerative Disorders Division Investigators

Abdulbaki Agbas, MSc, PhD, Department of Biochemistry, KCMB
Dora Agbas
, PhD, Molecular and Integrative Physiology
Heather Anderson, MD, Neurology
Richard Barohn, MD, Neurology
Andrei Belousov, PhD, Molecular and Integrative Physiology
Amanda Bruce, PhD, Hoglund Brain Imaging Center
Juan Bruses, PhD, Anatomy & Cell Biology
Jeff Burns, MD, MS, Neurology
Merlin Butler, MD, PhD, Psychiatry & Behavior Science
In-Young Choi, PhD, Hoglund Brain Imaging Center
Mazen Dimachkie, MD, Neurology
Richard Dobrowsky, PhD, Pharmacology, Toxicology & Therapeutics
Richard Dubinsky, MD, MPH, Neurology
Barry Festoff, MD, Neurology and Pharmacology, VAMC
Paige Geiger
, PhD, Molecular and Integrative Physiology
Nancy Hammond, MD, Neurology
Robyn Honea, Alzheimer and Memory Program
Michael Johnson, PhD, Chemistry - KU
Patricia Kluding, PT, PhD, SAH Physical Therapy Rehabilitation Sciences
Jeff Krise, PhD, Pharmaceutical Chemistry - KU
Robb Krumlauf, PhD, Anatomy & Cell Biology, Stowers
Phil Lee, PhD, Hoglund Brain Imaging Center
Steven Levine, PhD, Molecular and Integrative Physiology
Wen Liu, PhD, SAH Physical Therapy Rehabilitation Sciences
Sharon Lynch, MD, Neurology
Kelly Lyons, PhD, Neurology
Kenneth McCarson, PhD, Pharmacology, Toxicology & Therapeutics
Elias Michaelis, MD, PhD, Pharmacology, Toxicology & Therapeutics, KU
Mary Michaelis, PhD, Pharmacology, Toxicology & Therapeutics, KU
Nancy Muma, PhD, Pharmacology, Toxicology & Therapeutics
Jules Nazzaro, MD, Surgery Neurosurgery
Kathy Newell, MD, Pathology
Rajesh Pahwa, MD, Neurology
Mamatha Pasnoor, MD, Neurology
Alan Reeves, MD, Radiology
Michael Salacz, MD, Neuro-Oncology, Medical Oncology
Cary Savage, PhD, Hoglund Brain Imaging Center
Peter Smith,  PhD, KIDDRC
John Stanford, PhD, Molecular and Integrative Physiology
Russell Swerdlow, MD, Obstetrics and Gynecology
Sarah Taylor, MD, Hematology/Oncology
Fen Wang, MD, PhD, Radiation/Oncology
WenFang Wang, PhD, SAH Physical Therapy Rehabilitation Sciences
Yunxia Wang, MD, Neurology
Doug Wright, PhD, Anatomy & Cell Biology
C. Ron Yu, PhD, Anatomy & Cell Biology
Hao Zhu, PhD, SAH Physical Therapy Rehabilitation Sciences


Last modified: Feb 22, 2017
Division directors

Division Director:
Russ Swerdlow, MD

Associate Director:
Doug Wright, PhD

Research Goals

Our goal is to develop treatments that can arrest the progression of neurodegenerative diseases in affected persons and develop interventions to protect those at risk of developing a particular neurodegenerative disease.

Frequently Asked Questions


If you are experiencing symptoms and would like to make an appointment with a doctor, call 913-588-6820.

ID=x8176